OTTAWA, ON., Sept. 1, 2020 — Yesterday it was announced that Canada has signed an agreement in principle for 76 million doses of a potential COVID-19 vaccine from Novavax, a biotechnology company in the USA. The promising results from a small clinical trial, released at...